Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Operating Cash Flow

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Operating Cash Flow of -$14.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14

  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$14.71M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$16.20M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$17.63M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$13.76M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$66.44M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$42.10M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$25.81M.
  • VISTAGEN THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$49.72M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 157 monthNet Cash Provided by (Used in) Operating Activities 160 monthNet Cash Provided by (Used in) Operating Activities 163 monthNet Cash Provided by (Used in) Operating Activities 166 monthNet Cash Provided by (Used in) Operating Activities 169 monthNet Cash Provided by (Used in) Operating Activities 172 monthNet Cash Provided by (Used in) Operating Activities 175 monthNet Cash Provided by (Used in) Operating Activities 178 monthNet Cash Provided by (Used in) Operating Activities 181 monthNet Cash Provided by (Used in) Operating Activities 184 month
2026-06-30-$14.71M
10-Q · filed 2026-08-14
-$30.91M
derived: sum of 2 quarters · filed 2026-08-14
-$48.54M
derived: sum of 3 quarters · filed 2026-08-14
-$62.30M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$16.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
-$33.83M
derived: sum of 2 quarters · filed 2026-06-15
-$47.59M
derived: sum of 3 quarters · filed 2026-06-15
-$66.44M
10-K · filed 2026-06-15
2025-12-31-$17.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12
-$31.39M
derived: sum of 2 quarters · filed 2026-02-12
-$50.24M
10-Q · filed 2026-02-12
-$60.30M
derived: sum of 4 quarters · filed 2026-08-14
2025-09-30-$13.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13
-$32.60M
10-Q · filed 2025-11-13
-$42.67M
derived: sum of 3 quarters · filed 2026-08-14
-$52.95M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$18.85M
10-Q · filed 2026-08-14
-$28.91M
derived: sum of 2 quarters · filed 2026-08-14
-$39.19M
derived: sum of 3 quarters · filed 2026-08-14
-$50.07M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$10.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
-$20.34M
derived: sum of 2 quarters · filed 2026-06-15
-$31.23M
derived: sum of 3 quarters · filed 2026-06-15
-$42.10M
10-K · filed 2026-06-15
2024-12-31-$10.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12
-$21.17M
derived: sum of 2 quarters · filed 2026-02-12
-$32.03M
10-Q · filed 2026-02-12
-$39.02M
derived: sum of 4 quarters · filed 2026-02-12
2024-09-30-$10.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13
-$21.75M
10-Q · filed 2025-11-13
-$28.74M
derived: sum of 3 quarters · filed 2025-11-13
-$33.49M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$10.87M
10-Q · filed 2025-08-07
-$17.85M
derived: sum of 2 quarters · filed 2025-08-07
-$22.60M
derived: sum of 3 quarters · filed 2025-08-07
-$28.79M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$6.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17
-$11.73M
derived: sum of 2 quarters · filed 2025-06-17
-$17.92M
derived: sum of 3 quarters · filed 2025-06-17
-$25.81M
10-K · filed 2025-06-17
2023-12-31-$4.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13
-$10.94M
derived: sum of 2 quarters · filed 2025-02-13
-$18.83M
10-Q · filed 2025-02-13
-$18.62M
10-Q · filed 2024-02-13
-$26.30M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30-$6.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
-$14.08M
10-Q · filed 2024-11-07
-$14.08M
10-Q · filed 2023-11-09
-$21.55M
derived: sum of 3 quarters · filed 2024-11-07
-$31.49M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$7.89M
10-Q · filed 2024-08-13
-$7.89M
10-Q · filed 2023-08-10
-$15.36M
derived: sum of 2 quarters · filed 2024-08-13
-$25.30M
derived: sum of 3 quarters · filed 2024-08-13
-$41.64M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$7.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-11
-$17.41M
derived: sum of 2 quarters · filed 2024-06-11
-$33.75M
derived: sum of 3 quarters · filed 2024-06-11
-$49.72M
10-K · filed 2024-06-11
-$49.72M
10-K · filed 2023-06-28
2022-12-31-$9.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-13
-$26.27M
derived: sum of 2 quarters · filed 2024-02-13
-$42.24M
10-Q · filed 2024-02-13
-$57.83M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30-$16.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09
-$32.31M
10-Q · filed 2023-11-09
-$47.90M
derived: sum of 3 quarters · filed 2023-11-09
-$59.94M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$15.97M
10-Q · filed 2023-08-10
-$31.56M
derived: sum of 2 quarters · filed 2023-08-10
-$43.60M
derived: sum of 3 quarters · filed 2023-08-10
-$55.05M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$15.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28
-$27.63M
derived: sum of 2 quarters · filed 2023-06-28
-$39.08M
derived: sum of 3 quarters · filed 2023-06-28
-$45.26M
10-K · filed 2023-06-28
2021-12-31-$12.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-07
-$23.50M
derived: sum of 2 quarters · filed 2023-02-07
-$29.67M
10-Q · filed 2023-02-07
-$34.95M
derived: sum of 4 quarters · filed 2023-02-07
2021-09-30-$11.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10
-$17.62M
10-Q · filed 2022-11-10
-$17.62M
10-Q · filed 2021-11-10
-$27.89M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$6.17M
10-Q · filed 2022-08-11
-$11.45M
derived: sum of 2 quarters · filed 2022-08-11
-$16.44M
derived: sum of 3 quarters · filed 2022-08-11
-$15.44M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$5.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23
-$10.27M
derived: sum of 2 quarters · filed 2022-06-23
-$9.27M
derived: sum of 3 quarters · filed 2022-06-23
-$12.07M
10-K · filed 2022-06-23
2020-12-31-$4.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10
-$3.98M
derived: sum of 2 quarters · filed 2022-02-10
-$6.79M
10-Q · filed 2022-02-10
-$9.37M
derived: sum of 4 quarters · filed 2022-02-10
2020-09-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12
-$1.80M
10-Q · filed 2020-11-12
-$1.80M
10-Q · filed 2021-11-10
-$8.66M
derived: sum of 4 quarters · filed 2021-08-12
2020-06-30-$2.81M
10-Q · filed 2021-08-12
-$5.39M
derived: sum of 2 quarters · filed 2021-08-12
-$9.67M
derived: sum of 3 quarters · filed 2021-08-12
-$13.80M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$2.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29
-$6.86M
derived: sum of 2 quarters · filed 2021-06-29
-$11.00M
derived: sum of 3 quarters · filed 2021-06-29
-$15.76M
10-K · filed 2021-06-29
2019-12-31-$4.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11
-$8.42M
derived: sum of 2 quarters · filed 2021-02-11
-$13.18M
10-Q · filed 2021-02-11
-$16.73M
derived: sum of 4 quarters · filed 2021-02-11
2019-09-30-$4.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12
-$8.90M
10-Q · filed 2020-11-12
-$12.46M
derived: sum of 3 quarters · filed 2020-11-12
-$16.36M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$4.76M
10-Q · filed 2020-08-13
-$8.32M
derived: sum of 2 quarters · filed 2020-08-13
-$12.23M
derived: sum of 3 quarters · filed 2020-08-13
-$16.15M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29
-$7.46M
derived: sum of 2 quarters · filed 2020-06-29
-$11.39M
derived: sum of 3 quarters · filed 2020-06-29
-$14.53M
10-K · filed 2020-06-29
2018-12-31-$3.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13
-$7.83M
derived: sum of 2 quarters · filed 2020-02-13
-$10.97M
10-Q · filed 2020-02-13
-$13.57M
derived: sum of 4 quarters · filed 2020-02-13
2018-09-30-$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07
-$7.06M
10-Q · filed 2019-11-07
-$9.67M
derived: sum of 3 quarters · filed 2019-11-07
-$12.11M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$3.14M
10-Q · filed 2019-08-13
-$5.74M
derived: sum of 2 quarters · filed 2019-08-13
-$8.18M
derived: sum of 3 quarters · filed 2019-08-13
-$10.06M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25
-$5.05M
derived: sum of 2 quarters · filed 2019-06-25
-$6.92M
derived: sum of 3 quarters · filed 2019-06-25
-$9.06M
10-K · filed 2019-06-25
2017-12-31-$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12
-$4.32M
derived: sum of 2 quarters · filed 2019-02-12
-$6.45M
10-Q · filed 2019-02-12
2017-09-30-$1.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-29
-$4.01M
10-Q · filed 2018-10-29
2017-06-30-$2.13M
10-Q · filed 2018-08-14
2016-12-31-$2.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12
-$4.30M
derived: sum of 2 quarters · filed 2018-02-12
-$5.97M
10-Q · filed 2018-02-12
2016-09-30-$2.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09
-$3.87M
10-Q · filed 2017-11-09
2016-06-30-$1.67M
10-Q · filed 2017-08-14
2015-12-31-$1.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13
-$2.68M
derived: sum of 2 quarters · filed 2017-02-13
-$3.50M
10-Q · filed 2017-02-13
-$4.39M
derived: sum of 4 quarters · filed 2017-02-13
2015-09-30-$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14
-$2.33M
10-Q · filed 2016-11-14
-$3.22M
derived: sum of 3 quarters · filed 2016-11-14
-$3.56M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$823.30K
10-Q · filed 2016-08-12
-$1.72M
derived: sum of 2 quarters · filed 2016-08-12
-$2.06M
derived: sum of 3 quarters · filed 2016-08-12
-$2.58M
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31-$894.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29
-$1.24M
derived: sum of 2 quarters · filed 2016-02-16
-$1.76M
derived: sum of 3 quarters · filed 2016-02-16
-$2.77M
10-K · filed 2015-06-29
2014-12-31-$341.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16
-$862.60K
derived: sum of 2 quarters · filed 2016-02-16
-$1.87M
10-Q · filed 2016-02-16
-$2.34M
derived: sum of 4 quarters · filed 2016-02-16
2014-09-30-$521.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16
-$1.53M
10-Q · filed 2015-11-16
-$2.00M
derived: sum of 3 quarters · filed 2015-11-16
-$2.34M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30-$1.01M
10-Q · filed 2015-08-14
-$1.48M
derived: sum of 2 quarters · filed 2015-08-14
-$1.82M
derived: sum of 3 quarters · filed 2015-08-14
-$2.41M
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31-$467.10K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29
-$809.60K
derived: sum of 2 quarters · filed 2015-06-29
-$1.39M
derived: sum of 3 quarters · filed 2015-06-29
-$2.13M
10-K · filed 2015-06-29
-$23.10M
10-K · filed 2014-06-25
2013-12-31-$342.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17
-$927.10K
derived: sum of 2 quarters · filed 2015-02-17
-$1.66M
10-Q · filed 2015-02-17
-$2.63M
derived: sum of 4 quarters · filed 2015-02-17
-$22.63M
10-Q · filed 2014-02-14
2013-09-30-$584.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-19
-$1.32M
10-Q · filed 2014-11-19
-$2.29M
derived: sum of 3 quarters · filed 2014-11-19
-$3.25M
derived: sum of 4 quarters · filed 2014-11-19
-$22.29M
10-Q · filed 2013-11-14
2013-06-30-$731.80K
10-Q · filed 2014-08-12
-$1.70M
derived: sum of 2 quarters · filed 2014-08-12
-$2.66M
derived: sum of 3 quarters · filed 2014-08-12
-$3.90M
derived: sum of 4 quarters · filed 2014-08-12
-$21.70M
10-Q · filed 2013-08-14
2013-03-31-$970.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25
-$1.93M
derived: sum of 2 quarters · filed 2014-06-25
-$3.17M
derived: sum of 3 quarters · filed 2014-06-25
-$3.46M
10-K · filed 2014-06-25
-$20.97M
10-K · filed 2013-07-18
2012-12-31-$962.60K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14
-$2.20M
derived: sum of 2 quarters · filed 2014-02-14
-$2.49M
10-Q · filed 2014-02-14
-$3.21M
derived: sum of 4 quarters · filed 2014-02-14
-$20.00M
10-Q · filed 2013-02-14
2012-09-30-$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-14
-$1.53M
10-Q · filed 2013-11-14
-$2.25M
derived: sum of 3 quarters · filed 2013-11-14
-$3.31M
derived: sum of 4 quarters · filed 2013-11-14
-$19.04M
10-Q · filed 2012-11-14
2012-06-30-$296.20K
10-Q · filed 2013-08-14
-$1.01M
derived: sum of 2 quarters · filed 2013-08-14
-$2.07M
derived: sum of 3 quarters · filed 2013-08-14
-$2.78M
derived: sum of 4 quarters · filed 2013-08-14
-$17.80M
10-Q · filed 2012-08-14
2012-03-31-$718.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18
-$1.78M
derived: sum of 2 quarters · filed 2013-07-18
-$2.48M
derived: sum of 3 quarters · filed 2013-07-18
-$3.57M
10-K · filed 2013-07-18
-$17.51M
10-K · filed 2012-07-02
2011-12-31-$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14
-$1.76M
derived: sum of 2 quarters · filed 2013-02-14
-$2.85M
10-Q · filed 2013-02-14
-$2.85M
10-Q · filed 2012-02-14
-$2.94M
derived: sum of 4 quarters · filed 2013-02-14
-$16.79M
10-Q · filed 2012-02-14
2011-09-30-$702.20K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14
-$1.79M
10-Q · filed 2012-11-14
-$1.79M
10-Q · filed 2011-11-14
-$1.88M
derived: sum of 3 quarters · filed 2012-11-14
-$1.86M
derived: sum of 4 quarters · filed 2012-11-14
-$15.73M
10-Q · filed 2011-11-14
2011-06-30-$1.09M
10-Q · filed 2012-08-14
-$1.09M
10-Q · filed 2011-08-22
-$1.18M
derived: sum of 2 quarters · filed 2012-08-14
-$1.16M
derived: sum of 3 quarters · filed 2012-08-14
-$1.60M
derived: sum of 4 quarters · filed 2012-08-14
-$15.03M
10-Q · filed 2011-08-22
2011-03-31-$90.42K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02
-$72.75K
derived: sum of 2 quarters · filed 2012-07-02
-$515.98K
derived: sum of 3 quarters · filed 2012-07-02
-$841.30K
10-K · filed 2012-07-02
2010-12-31$17.67K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14
-$425.56K
derived: sum of 2 quarters · filed 2012-02-14
-$750.88K
10-Q · filed 2012-02-14
2010-09-30-$443.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14
-$768.55K
10-Q · filed 2011-11-14
2010-06-30-$325.32K
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B